
PLx Pharma Inc.
PLx Pharma Inc.(PLXP)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · PLXP · 截至 2026年6月9日
活动摘要
买入笔数
12
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
PLx Pharma Inc.内部人在过去近12个月净买入股份,可能反映对公司前景的信心。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
PLXP 季度内部人买卖趋势
PLXP 内幕交易卖出 · PLXP 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
PLXP 高管卖出股份 · PLXP 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 15, 2022 | Giordano Natasha CEO | Purchase | 4,100 | $15K | Form 4 |
| Mar 15, 2022 | O'Connor Rita M CFO | Purchase | 3,700 | $14K | Form 4 |
| Mar 15, 2022 | O'Connor Rita M CFO | Purchase | 10,000 | $37K | Form 4 |
| Jun 14, 2021 | Valentino Michael J Executive Chairman · Director | Purchase | 120 | $2K | Form 4 |
| Jun 14, 2021 | Valentino Michael J Executive Chairman · Director | Purchase | 5,080 | $64K | Form 4 |
| Jun 14, 2021 | Valentino Michael J Executive Chairman · Director | Purchase | 100 | $1K | Form 4 |
| Jun 14, 2021 | Valentino Michael J Executive Chairman · Director | Purchase | 300 | $4K | Form 4 |
| Jun 14, 2021 | Valentino Michael J Executive Chairman · Director | Purchase | 600 | $7K | Form 4 |
| Jun 14, 2021 | Valentino Michael J Executive Chairman · Director | Purchase | 100 | $1K | Form 4 |
| Jun 14, 2021 | Valentino Michael J Executive Chairman · Director | Purchase | 100 | $1K | Form 4 |
| Jun 14, 2021 | Valentino Michael J Executive Chairman · Director | Purchase | 400 | $5K | Form 4 |
| Jun 14, 2021 | Valentino Michael J Executive Chairman · Director | Purchase | 1,200 | $15K | Form 4 |
| Mar 5, 2021 | Valentino Michael J Executive Chairman · Director | Purchase | 25,000 | $200K | Form 4 |
| Dec 14, 2020 | HADDEN JOHN Director | Purchase | 400 | $2K | Form 4 |
| Dec 14, 2020 | HADDEN JOHN Director | Purchase | 600 | $3K | Form 4 |
| Nov 25, 2020 | HADDEN JOHN Director | Purchase | 500 | $3K | Form 4 |
| Nov 18, 2020 | Valentino Michael J Executive Chairman · Director | Purchase | 264,900 | $1.00M⚡ | Form 4 |
| Sep 2, 2020 | O'Connor Rita M CFO | Purchase | 2,120 | $8K | Form 4 |
| Sep 1, 2020 | O'Connor Rita M CFO | Purchase | 4,500 | $17K | Form 4 |
| Aug 21, 2020 | O'Connor Rita M CFO | Purchase | 4,050 | $16K | Form 4 |
| Aug 20, 2020 | O'Connor Rita M CFO | Purchase | 2,300 | $9K | Form 4 |
| May 20, 2019 | Valentino Michael J Executive Chairman · Director | Purchase | 44,404 | $249K | Form 4 |
| Aug 10, 2017 | Valentino Michael J Executive Chairman · Director | Award | 30,000 | — | Form 4 |
| Jun 14, 2017 | JORDEN DAVID EMERSON Acting Chief Financial Officer | Purchase | 32,727 | $225K | Form 4 |
| Jun 14, 2017 | MOSSMAN GARY L COO | Purchase | 7,273 | $50K | Form 4 |
Valentino Michael J
Executive Chairman · Director
日期
Jun 14
股数
120
均价
$12.51
总金额
$2K
Valentino Michael J
Executive Chairman · Director
日期
Jun 14
股数
5,080
均价
$12.50
总金额
$64K
Valentino Michael J
Executive Chairman · Director
日期
Jun 14
股数
100
均价
$12.48
总金额
$1K
Valentino Michael J
Executive Chairman · Director
日期
Jun 14
股数
300
均价
$12.47
总金额
$4K
Valentino Michael J
Executive Chairman · Director
日期
Jun 14
股数
600
均价
$12.47
总金额
$7K
Valentino Michael J
Executive Chairman · Director
日期
Jun 14
股数
100
均价
$12.46
总金额
$1K
Valentino Michael J
Executive Chairman · Director
日期
Jun 14
股数
100
均价
$12.45
总金额
$1K
Valentino Michael J
Executive Chairman · Director
日期
Jun 14
股数
400
均价
$12.45
总金额
$5K
Valentino Michael J
Executive Chairman · Director
日期
Jun 14
股数
1,200
均价
$12.44
总金额
$15K
Valentino Michael J
Executive Chairman · Director
日期
Mar 5
股数
25,000
均价
$8.00
总金额
$200K
Valentino Michael J
Executive Chairman · Director
日期
Nov 18
股数
264,900
均价
$3.79
总金额
$1.00M ⚡
Valentino Michael J
Executive Chairman · Director
日期
May 20
股数
44,404
均价
$5.60
总金额
$249K
JORDEN DAVID EMERSON
Acting Chief Financial Officer
日期
Jun 14
股数
32,727
均价
$6.88
总金额
$225K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 PLXP 内幕交易
PLXP 内幕交易
PLx Pharma Inc.(PLXP)内幕交易数据来源于公司内部人(包括PLXP)提交的SEC Form 4申报文件。过去12个月内,0位内部人向SEC提交了交易申报。PLXP内部人近期主要在买入,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看PLx Pharma Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
PLXP 内幕交易 · 5个问题PLx Pharma Inc.(PLXP)的内部人包括高管和董事,如PLXP等。过去12个月内,0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026